Article
BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma
3 Mar 2021
Abstract excerpt
Bradykinin receptor B2 (BDKRB2) has been reported as an oncogene in several malignancies. In glioma, the role of BDKRB2 remains unknown. This study aimed at investigating its clinical significance and biological function in glioma at the transcriptional level. We selected 301 glioma patients with microarray data from CGGA database and 697 with RNAseq data from TCGA database. Transcriptome and clinical data of 998...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
